← Back
$QNCX All transactions

Quince Therapeutics, Inc.

A

$ Value

$0

Shares

1,000,000

Price

$0

Filed

Jan 23

Insider

Name

Thye Dirk

Title

CEO and CMO

CIK

0001638945

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-23

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,000,000

Footnotes

The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting with 1/48th vesting on the date of grant and the remaining options vesting on the 1st day of each subsequent month, such that the total number of shares shall be fully vested on December 1, 2029.

Filing Info

Accession No.

0000912282-26-000121

Form Type

4

Issuer CIK

0001662774

Thye Dirk's History

Date Ticker Type Value
2026-01-23 QNCX A $0
2025-12-10 QNCX G $0
2025-12-10 QNCX G $0
2025-06-18 QNCX A $181K
2025-06-18 QNCX A $19K

Other Insiders at QNCX (90d)

No other insider activity at this issuer in the last 90 days.